CL Shapiro
Impact in
-
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 4
- Cancer-related Molecular Pathways 1
-
- Histone Deacetylase Inhibitors Research 1
- Natural product bioactivities and synthesis 1
- Co-authors
- Daniel F. Hayes (3 shared papers)I. Craig Henderson (2 shared papers)Ewa Mrózek (2 shared papers)Kalpana Ghoshal (1 shared paper)Jharna Datta (1 shared paper)Sarmila Majumder (1 shared paper)William E. Barlow (1 shared paper)R T Osteen (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Research (3 papers)JNCI Journal of the National Cancer Institute (1 paper)PubMed (1 paper)
- Partner nations
- United States
In The Last Decade
CL Shapiro
9 papers receiving 124 citations
Peers
Comparison fields: 5 of 40
- Cancer Research 58
- Oncology 85
- Dermatology 14
- Genetics 30
- Pulmonary and Respiratory Medicine 30
Countries citing papers authored by CL Shapiro
This map shows the geographic impact of CL Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CL Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CL Shapiro more than expected).
Fields of papers citing papers by CL Shapiro
This network shows the impact of papers produced by CL Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CL Shapiro. The network helps show where CL Shapiro may publish in the future.
Co-authors
The 25 scholars most cited alongside CL Shapiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Treatment of metastatic breast cancer: present and future prospects. | 1995 | 57 |
| 2 | 2009 | 28 | |
| 3 | 2009 | 20 | |
| 4 | 1993 | 10 | |
| 5 | 2005 | 5 | |
| 6 | 2011 | 3 | |
| 7 | 2008 | 2 | |
| 8 | 2011 | 2 | |
| 9 | 2017 | 1 |
About CL Shapiro
CL Shapiro is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Pharmacology, having authored 9 papers that have together received 128 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (2 papers), Advanced Breast Cancer Therapies (2 papers), MicroRNA in disease regulation (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Cancer-related Molecular Pathways (1 paper), Lung Cancer Treatments and Mutations (1 paper) and Natural product bioactivities and synthesis (1 paper). The work is most often cited by research in Cancer Research (58 citations), Oncology (85 citations), Dermatology (14 citations), Genetics (30 citations) and Pulmonary and Respiratory Medicine (30 citations). CL Shapiro has collaborated with scholars based in United States. Frequent co-authors include Daniel F. Hayes, I. Craig Henderson, Ewa Mrózek, Kalpana Ghoshal, Jharna Datta, Sarmila Majumder, William E. Barlow, R T Osteen, I‐Tien Yeh and R. B. Livingston. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, JNCI Journal of the National Cancer Institute and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.